AbbVie Revenue Growth & History (ABBV)

AbbVie reported $61.16B in revenue for fiscal 2025, an increase of 8.57% from the previous fiscal year.

View full AbbVie company overview

AbbVie annual revenue and growth

AbbVie annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-12-31$61.16B$4.83B+8.57%
20242024-12-31$56.33B$2.02B+3.71%
20232023-12-31$54.32B−$3.74B−6.44%
20222022-12-31$58.05B$1.86B+3.30%
20212021-12-31$56.20B$10.39B+22.69%
20202020-12-31$45.80B$12.54B+37.69%
20192019-12-31$33.27B$513.0M+1.57%
20182018-12-31$32.75B$4.54B+16.08%
20172017-12-31$28.22B$2.58B+10.06%
20162016-12-31$25.64B$2.78B+12.16%
20152015-12-31$22.86B$2.90B+14.52%
20142014-12-31$19.96B$1.17B+6.23%
20132013-12-31$18.79B$410.0M+2.23%
20122012-12-31$18.38B$936.0M+5.37%
20112011-12-31$17.44B
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review AbbVie filings at SEC.gov ↗